Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 31;13(33):23087-23121.
doi: 10.1039/d3ra03369d. eCollection 2023 Jul 26.

Recent developments in natural biopolymer based drug delivery systems

Affiliations
Review

Recent developments in natural biopolymer based drug delivery systems

Tanzeela Fazal et al. RSC Adv. .

Abstract

Targeted delivery of drug molecules to diseased sites is a great challenge in pharmaceutical and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or diagnose sick cells is an effective means to achieve good therapeutic results along with a minimal toxicological impact on healthy cells. Biopolymers are becoming an important class of materials owing to their biodegradability, good compatibility, non-toxicity, non-immunogenicity, and long blood circulation time and high drug loading ratio for both macros as well as micro-sized drug molecules. This review summarizes the recent trends in biopolymer-based DDS, forecasting their broad future clinical applications. Cellulose chitosan, starch, silk fibroins, collagen, albumin, gelatin, alginate, agar, proteins and peptides have shown potential applications in DDS. A range of synthetic techniques have been reported to design the DDS and are discussed in the current study which is being successfully employed in ocular, dental, transdermal and intranasal delivery systems. Different formulations of DDS are also overviewed in this review article along with synthesis techniques employed for designing the DDS. The possibility of these biopolymer applications points to a new route for creating unique DDS with enhanced therapeutic qualities for scaling up creative formulations up to the clinical level.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1. Classification of different polysaccharide, protein and nucleotide-based biopolymers.

Similar articles

Cited by

References

    1. Wróblewska-Krepsztul J. et al., Biopolymers for Biomedical and Pharmaceutical Applications: Recent Advances and Overview of Alginate Electrospinning. Nanomaterials. 2019;9:404. - PMC - PubMed
    1. Talebian S. et al., Biopolymers for antitumor implantable DDS: recent advances and future outlook. Adv. Mater. 2018;30(31):1706665. - PubMed
    1. Gagliardi A. et al., Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system. Int. J. Nanomed. 2018;13:601. - PMC - PubMed
    1. García M. C., DDS based on nonimmunogenic biopolymers, in Engineering of Biomaterials for DDS, Elsevier, 2018, pp. 317–344
    1. Chen X. et al., Ultra-selective molecular-sieving gas separation membranes enabled by multi-covalent-crosslinking of microporous polymer blends. Nat. Commun. 2021;12(1):6140. - PMC - PubMed